1
Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy
Condition(s):Polymyositis; DermatomyositisLast Updated:August 26, 2016Completed
Dermatomyositis: 132 Clinical Trials, Page 1 of 14
Hide Studies Not Open or Pending
2
Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis
Condition(s):Dermatomyositis, Adult TypeLast Updated:July 8, 2021Completed
3
An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
Condition(s):Dermatomyositis; AbataceptLast Updated:July 1, 2021Recruiting
4
Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
Condition(s):Dermatomyositis; Juvenile DermatomyositisLast Updated:September 16, 2021Completed
5
Juvenile Dermatomyositis
Condition(s):Juvenile DermatomyositisLast Updated:February 27, 2018Unknown status
6
Gastric Mucosal Changes in Patients With Dermatomyositis
Condition(s):Gastric Mucosal Manifestations in Patients With DermatomyositisLast Updated:June 2, 2022Recruiting
7
Baricitinib in Patients With Relapsing or naïve Dermatomyositis
Condition(s):DermatomyositisLast Updated:June 8, 2022Not yet recruiting
8
The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients
Condition(s):Dermatomyositis, Adult TypeLast Updated:July 19, 2021Recruiting
9
Incidence and Prevalence of Juvenile Dermatomyositis
Condition(s):Juvenile DermatomyositisLast Updated:February 14, 2018Unknown status
10
Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis
Condition(s):DermatomyositisLast Updated:March 29, 2021Terminated